ALTEOGEN Future Growth
Future criteria checks 6/6
ALTEOGEN is forecast to grow earnings and revenue by 130.7% and 78.4% per annum respectively. EPS is expected to grow by 130.6% per annum. Return on equity is forecast to be 67.6% in 3 years.
Key information
130.7%
Earnings growth rate
130.6%
EPS growth rate
Biotechs earnings growth | 81.7% |
Revenue growth rate | 78.4% |
Future return on equity | 67.6% |
Analyst coverage | Low |
Last updated | 26 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 422,800 | 308,700 | 276,700 | 297,050 | 2 |
12/31/2025 | 103,267 | 25,033 | 18,400 | 17,033 | 3 |
12/31/2024 | 84,500 | 23,000 | 8,350 | 25,150 | 2 |
9/30/2024 | 74,375 | -2,906 | -11,253 | 21,653 | N/A |
6/30/2024 | 90,788 | -1,282 | -17,338 | 16,054 | N/A |
3/31/2024 | 121,087 | 25,542 | -5,931 | 31,966 | N/A |
12/31/2023 | 96,523 | -3,372 | -51,203 | -7,766 | N/A |
9/30/2023 | 85,036 | 6,459 | -47,997 | -5,918 | N/A |
6/30/2023 | 69,154 | 7,865 | -54,448 | -10,137 | N/A |
3/31/2023 | 32,199 | -21,798 | -65,152 | -17,104 | N/A |
12/31/2022 | 28,806 | -8,146 | -60,366 | -17,875 | N/A |
9/30/2022 | 32,292 | 1,367 | -48,159 | -3,432 | N/A |
6/30/2022 | 33,065 | -223 | -38,075 | -3,080 | N/A |
3/31/2022 | 33,807 | -1,243 | -36,477 | -6,327 | N/A |
12/31/2021 | 38,746 | -6,275 | -33,536 | -9,461 | N/A |
9/30/2021 | 29,498 | -38,971 | -38,304 | -24,242 | N/A |
6/30/2021 | 37,316 | -26,975 | -13,157 | 600 | N/A |
3/31/2021 | 44,433 | -17,748 | -5,171 | 147 | N/A |
12/31/2020 | 42,426 | -15,822 | -4,016 | 1,512 | N/A |
9/30/2020 | 51,935 | 15,424 | 14,537 | 21,726 | N/A |
6/30/2020 | 43,420 | 9,040 | -2,991 | 5,475 | N/A |
3/31/2020 | 35,242 | 5,001 | -103 | 9,187 | N/A |
12/31/2019 | 29,229 | -705 | 804 | 9,133 | N/A |
9/30/2019 | 18,012 | -7,900 | -12,042 | -7,301 | N/A |
6/30/2019 | 15,796 | -8,574 | -18,254 | -8,421 | N/A |
3/31/2019 | 13,473 | -8,078 | -15,481 | -7,995 | N/A |
12/31/2018 | 13,703 | -6,872 | -16,472 | -9,113 | N/A |
9/30/2018 | 13,079 | -11,776 | -15,102 | -8,027 | N/A |
6/30/2018 | 12,610 | -9,945 | N/A | -7,065 | N/A |
3/31/2018 | 11,788 | -10,332 | N/A | -6,763 | N/A |
12/31/2017 | 12,104 | -7,449 | N/A | -4,347 | N/A |
9/30/2017 | 11,815 | -2,837 | N/A | -6,028 | N/A |
6/30/2017 | 11,567 | -2,871 | N/A | -1,809 | N/A |
3/31/2017 | 10,569 | -1,961 | N/A | -2,797 | N/A |
12/31/2016 | 6,844 | -3,587 | N/A | -3,159 | N/A |
9/30/2016 | 6,088 | -1,481 | N/A | 1,869 | N/A |
6/30/2016 | 4,213 | -201 | N/A | -902 | N/A |
3/31/2016 | 3,634 | -136 | N/A | 1,726 | N/A |
12/31/2015 | 4,727 | 1,208 | N/A | 2,264 | N/A |
9/30/2015 | 4,585 | 337 | N/A | 1,210 | N/A |
6/30/2015 | 5,686 | 320 | N/A | 2,476 | N/A |
3/31/2015 | 6,874 | 1,209 | N/A | 1,074 | N/A |
12/31/2014 | 7,043 | 931 | N/A | 1,210 | N/A |
9/30/2014 | 6,753 | 1,158 | N/A | 898 | N/A |
6/30/2014 | 6,257 | 1,224 | N/A | -255 | N/A |
3/31/2014 | 6,003 | 1,434 | N/A | 1,118 | N/A |
12/31/2013 | 5,527 | 1,606 | N/A | 1,995 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A196170 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.7%).
Earnings vs Market: A196170 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A196170 is expected to become profitable in the next 3 years.
Revenue vs Market: A196170's revenue (78.4% per year) is forecast to grow faster than the KR market (9% per year).
High Growth Revenue: A196170's revenue (78.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A196170's Return on Equity is forecast to be very high in 3 years time (67.6%).